Fresenius Medical Care Renal Therapies Group, LLC recalls Citrasate
- Recalling company
- Fresenius Medical Care Renal Therapies Group, LLC
- Product
- Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis
- Reason
- Complaints of blue-green discoloration in product
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 14, 2026
- Reported
- Sep 9, 2026
- Distribution
- Worldwide distribution - US Nationwide and the country of Mexico.
- Status
- Ongoing
- Quantity
- 56,036 cs; 1,788 drums; 204 ea
- Lot / codes
- 1) 08-2251-CA, UDI/DI 00840861101344, Lot Numbers: 26BXAC038; 2) 08-3251-CA, UDI/DI 00840861101351, Lot Numbers: 26BXAC039; 3) 13-2251-CA, UDI/DI 00840861101375, Lot Numbers: 26BXAC040, 26BXAC041.
- Company location
- Waltham, MA
- Recall type
- Voluntary: Firm initiated
- Recall number
- Z-3093-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number Z-3093-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.